Would you offer a complement inhibitor to a minimally symptomatic PNH patient with mild non-transfusion dependent hemolytic anemia?
Answer from: at Academic Institution
The context would determine whether this patient should receive complement inhibitor. The first consideration is whether the patient has concurrent aplastic anemia or bone marrow failure. Often, patients with aplastic anemia have a small PNH clone that is not clinically significant and does not caus...
Comments
at Kaiser Permanente, Los Angeles Med Center Super helpful, thank you so much for taking the ti...
Super helpful, thank you so much for taking the ti...